SCHEMBL2695665

SCHEMBL2695665

CC(C)C[C@H](N)C(=O)OC(=O)[C@@H](N)CCC(N)=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.47
BLM P54132 1/20 0.47
PMP22 Q01453 1/20 0.47
KMT2A Q03164 1/20 0.47
SLC7A5 Q01650 1/20 0.44
DPP4 P27487 1/20 0.42
DPP8 Q6V1X1 1/20 0.42
DPP9 Q86TI2 1/20 0.42
FOLH1 Q04609 1/20 0.39
ANPEP P15144 5/20 0.38
RNPEP Q9H4A4 2/20 0.38
DNPEP Q9ULA0 1/20 0.38
SLC1A3 P43003 3/20 0.35
SLC1A2 P43004 3/20 0.35
SLC1A1 P43005 2/20 0.33
GABRP O00591 2/20 0.31
GABRD O14764 2/20 0.31
GABRA1 P14867 2/20 0.31
GABRB1 P18505 2/20 0.31
GABRG2 P18507 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12497981 1.00 ALOX15 (0.47) ALOX15BLMPMP22KMT2ASLC7A5
SCHEMBL28313344 0.87 ALOX15 (0.60) ALOX15BLMPMP22KMT2ADPP4
SCHEMBL711607 0.87 ALOX15 (0.60) ALOX15BLMPMP22KMT2ADPP4
SCHEMBL3402622 0.86 GABRP (0.48) SLC7A5DPP4DPP8DPP9FOLH1
SCHEMBL1537429 0.86 SLC7A5 (0.44) ALOX15BLMPMP22KMT2ASLC7A5
SCHEMBL432399 0.85 PMP22 (0.50) ALOX15BLMPMP22KMT2ADPP4
SCHEMBL995721 0.84 SLC7A5 (0.58) SLC7A5DPP4DPP8DPP9ANPEP
SCHEMBL9100153 0.84 SLC7A5 (0.58) SLC7A5DPP4DPP8DPP9ANPEP
SCHEMBL27469444 0.84 SLC7A5 (0.42) SLC7A5FOLH1ANPEPRNPEPDNPEP
SCHEMBL508161 0.84 ALOX15 (0.48) ALOX15BLMPMP22KMT2ADPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1084137-A1 PEPTIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) 2001-03-21 EP claimed
EP-0514509-B1 COMPOSITION AND ITS PREPARATION PROCESS USING ANTIGEN CONJUGATED TO ENZYMATIC ACTIVITY FOR IMMUNOLOGICAL DIAGNOSIS AND CHAGAS' DISEASE IMMUNOLOGICAL DIAGNOSIS KITS, FOR INDIVIDUAL AND EPIDEMIOLOGICAL APPLICATION, BASED ON THAT COMPOSITION FUNDACAO OSWALDO CRUZ (BR) 2000-09-20 EP claimed
WO-1999064442-A1 PEPTIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI S.P.A. (IT) 1999-12-16 WO claimed
WO-2024123572-A1 METHODS FOR IMPROVING BONE HEALTH WITH BOVINE MILK EXOSOME-ENRICHED PRODUCTS AND VITAMIN K2 ABBOTT LABORATORIES (US) 2024-06-13 WO disclosed
US-20240058386-A1 METHOD FOR IMPROVING JOINT HEALTH BY ADMINISTERING BOVINE MILK-DERIVED EXOSOMES ABBOTT LABORATORIES 2024-02-22 US disclosed
WO-2024025934-A1 METHODS FOR PROMOTING HEALTHY CATCH-UP GROWTH ABBOTT LABORATORIES (US) 2024-02-01 WO disclosed
WO-2024015441-A1 BOVINE MILK EXOSOMES FOR DELIVERING VITAMIN K2 AND INCREASING BIOAVAILABILITY ABBOTT LABORATORIES (US) 2024-01-18 WO disclosed
US-20240009245-A1 METHODS OF INCREASING HEIGHT AND PROMOTING LINEAR BONE GROWTH ABBOTT LABORATORIES 2024-01-11 US disclosed
EP-4271397-A1 METHOD FOR IMPROVING JOINT HEALTH BY ADMINISTERING BOVINE MILK-DERIVED EXOSOMES ABBOTT LABORATORIES (US) 2023-11-08 EP disclosed
EP-4271192-A1 METHODS FOR ENHANCING MUSCLE PERFORMANCE OR REDUCING CHRONIC FATIGUE BY ADMINISTERING BOVINE MILK-DERIVED EXOSOMES ABBOTT LABORATORIES (US) 2023-11-08 EP disclosed
EP-4247176-A2 METHODS OF INCREASING HEIGHT AND PROMOTING LINEAR BONE GROWTH ABBOTT LABORATORIES (US) 2023-09-27 EP disclosed
US-20120252719-A1 WATER SOLUBLE MEMBRANE PROTEINS AND METHODS FOR THE PREPARATION AND USE THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2012-10-04 US disclosed
US-8168241-B2 For enhancing physical performance of human, foods RELIV INTERNATIONAL, INC. (US) 2012-05-01 US disclosed
US-20100009346-A1 Lafora's disease gene THE HOSPITAL FOR SICK CHILDREN 2010-01-14 US disclosed
US-7550571-B2 Using presence of polymorphism in nucleotide sequences coding protein tyrosine phosphatase to diagnose epileptic disorders; antiepileptic agents MCGRILL UNIVERSITY (CA) 2009-06-23 US disclosed
US-20060105419-A1 Use of a glutathione peroxidase 1 as a marker in cardiovascular conditions BIOSITE, INC. 2006-05-18 US disclosed
US-6825328-B1 Lafora's disease gene THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2004-11-30 US disclosed
US-20040170709-A1 Performance-enhancing dietary supplement RELIV' INTERNATIONAL INC 2004-09-02 US disclosed
US-20010041187-A1 PERFORMANCE-ENHANCING DIETARY SUPPLEMENT RELIV' INTERNATIONAL, INC. 2001-11-15 US disclosed
EP-0514509-B1 COMPOSITION AND ITS PREPARATION PROCESS USING ANTIGEN CONJUGATED TO ENZYMATIC ACTIVITY FOR IMMUNOLOGICAL DIAGNOSIS AND CHAGAS' DISEASE IMMUNOLOGICAL DIAGNOSIS KITS, FOR INDIVIDUAL AND EPIDEMIOLOGICAL APPLICATION, BASED ON THAT COMPOSITION FUNDACAO OSWALDO CRUZ (BR) 2000-09-20 EP disclosed